Ally Pharma Options Private Limited

Ally Pharma Options Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH2003PTC138511 Incorporated 02 January 2003 ROC Mumbai HQ Mumbai, Maharashtra, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2015
₹39.79 Cr
▲ 37% YoY
Net profit · FY 2015
₹1.96 Cr
Net margin 4.9%
EBITDA · FY 2015
₹6.56 Cr
EBITDA margin 16.5%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹2.9 Cr
Issued & subscribed
Satisfied charges
₹16.66 Cr
No open charges
Company age
23 yrs
Est. 2003
Directors on board
3
As per MCA filings

About Ally Pharma Options Private Limited

Data last updated:

Ally Pharma Options Private Limited was a private limited company based in Mumbai, Maharashtra, India. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 January 2003.

The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2003PTC138511. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.9 Cr. It was led by directors including Mehul Madan Sakhala (Whole-Time Director) and Hemlata Madanlal Sakhala.

Its last annual general meeting (AGM) was held on 30 September 2015, and its latest financial statements are for the year ended 31 March 2015. The registered office was at Mumbai, Maharashtra.

As per the financials filed for FY 2015, the company reported a revenue of ₹39.79 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹1.96 Cr (net margin 4.9%) and EBITDA of ₹6.56 Cr (EBITDA margin 16.5%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years.

As per MCA filings, the company had satisfied charges of ₹16.66 Cr on record. Court records list 7 cases involving the company, including 2 filed by the company and 5 filed against it.

Company Details of Ally Pharma Options Private Limited
CIN U24230MH2003PTC138511
Registration Number 138511
Incorporation Date 02 January 2003
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 September 2015
Date of Balance Sheet 31 March 2015
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    301 3rd Floor Maxheal House Plot No. 169 Cst No. 1043 Bangur Nagar Goregaon (We, St), Mumbai, Maharashtra, India – 400090
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Ally Pharma Options Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Ally Pharma Options Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ally Pharma Options Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Financials of Ally Pharma Options Private Limited FY 2015 filings available

Ally Pharma Options Private Limited reported revenue of ₹39.79 Cr (up 37% YoY) for FY 2015.

Revenue · FY 2015
₹39.79 Cr ▲ 37%
Net profit · FY 2015
₹1.96 Cr margin 4.9%
EBITDA · FY 2015
₹6.56 Cr margin 16.5%

Compounded Annual Growth Rate (CAGR) of Ally Pharma Options Private Limited

Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 52%
3 years · compounded
▲ 42%

Revenue has grown at a compounded annual rate (CAGR) of 25% over three years, including 37% growth in the latest year. EBITDA rose 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Ally Pharma Options Private Limited

MetricsFY 2014-15
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue₹39.79 Cr
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA₹6.56 Cr
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)₹1.96 Cr
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Ally Pharma Options Private Limited

MetricsFY 2014-15
Profitability
EBITDA Margin16.5%
Net Profit Margin4.9%
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ally Pharma Options are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Auditor Details of Ally Pharma Options Private Limited

Ally Pharma Options Private Limited is audited by PHIRODIA BAFNA & ASSOCIATES for the financial year 2015.

NameStatusAppointment DateCessation Date
PHIRODIA BAFNA & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Ally Pharma Options Private Limited

Ally Pharma Options has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Hemlata Madanlal SakhalaDirector14 Oct 200817 Years 11 MonthsAs last reported
Madanlal Mohanlal SakhalaDirector14 Oct 200817 Years 11 MonthsAs last reported
Mehul Madan SakhalaWhole-Time Director14 Oct 200817 Years 11 MonthsAs last reported

Ownership and Shareholding of Ally Pharma Options Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ally Pharma Options Private Limited

Open charges
None
Satisfied charges
₹16.66 Cr
Breakdown by lending institutions
State Bank of India₹16.66 Cr
Latest charge details
DateLenderAmountStatus
20 Jan 2004State Bank of India₹6.1 CrSatisfied
20 Jan 2004State Bank of India₹10.56 CrSatisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Ally Pharma Options Private Limited

Employment history and EPFO contributions of people linked to Ally Pharma Options.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Ally Pharma Options Private Limited

Ally Pharma Options Private Limited has 10 board changes on record since 2008: 3 appointments and 7 cessations. The latest: Mehul Madan Sakhala ceased to be Director on 01 Jul 2012.

AGM
Ally Pharma Options Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records.
Charges
A charge registered on 20 Jan 2004 via Charge ID 90146577 with State Bank Of India was fully satisfied on 10 Jun 2015.
Charges
A charge registered on 20 Jan 2004 via Charge ID 80005732 with State Bank Of India was fully satisfied on 10 Jun 2015.
Filing
Ally Pharma Options Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Mumbai.
Ceased
Mehul Madan Sakhala ceased to be Director.
Ceased
Virendra Laxmidas Thakkar ceased to be Director.
Ceased
Ashok Rupchand Panjwani ceased to be Director.
Ceased
Anupkumar Nathmal Hisaria ceased to be Director.
Ceased
Jagdish Harilal Parekh ceased to be Director.
Ceased
Manoj Tiwari Bhushan ceased to be Director.
Ceased
Rajnikant Harilal Parekh ceased to be Director.
Appointed
Hemlata Madanlal Sakhala was appointed as Director.

7 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Ally Pharma Options Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ally Pharma Options Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ally Pharma Options Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Ally Pharma Options Private Limited

Ally Pharma Options has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ally Pharma Options Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ally Pharma Options Private Limited

Ally Pharma Options has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Ally Pharma Options was a private limited company based in Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 02 January 2003 and is registered under CIN U24230MH2003PTC138511. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.

Ally Pharma Options was incorporated on 02 January 2003. It is registered with the Registrar of Companies, Mumbai.

Ally Pharma Options had 3 directors:

The CIN (Corporate Identification Number) of Ally Pharma Options is U24230MH2003PTC138511. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Ally Pharma Options is at 301 3rd Floor Maxheal House Plot No. 169 Cst No. 1043 Bangur Nagar Goregaon We, St, Mumbai, Maharashtra, India – 400090.

Ally Pharma Options reported revenue of ₹39.79 Cr for FY 2015 (up 37% YoY).

Ally Pharma Options has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.9 Cr.

Ally Pharma Options reported a net profit of ₹1.96 Cr (net margin 4.9%) and EBITDA of ₹6.56 Cr (EBITDA margin 16.5%) for FY 2015, as per its filed financial statements.

No. Ally Pharma Options has 1 GST registration on record and it is cancelled or inactive.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available